Email Updates
Study
Major congenital malformations after first-trimester exposure to ACE inhibitors.
February 17, 2011
Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. New England Journal of Medicine. 2006;354(23).
This U.S. Food and Drug Administration (FDA)– and AHRQ–funded study documents the possibility of adverse effects on the fetus when mothers take angiotensin-converting enzyme (ACE) inhibitors during the first trimester of pregnancy.
